Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$20.69 - $20.91 $2.92 Million - $2.95 Million
140,958 Added 47.05%
440,541 $9.2 Million
Q2 2022

Aug 12, 2022

BUY
$13.8 - $20.82 $1.28 Million - $1.94 Million
93,097 Added 45.09%
299,583 $6.22 Million
Q1 2022

May 18, 2022

SELL
$15.96 - $18.87 $3,128 - $3,698
-196 Reduced 0.09%
206,486 $3.47 Million
Q1 2022

May 13, 2022

BUY
$15.96 - $18.87 $81,316 - $96,142
5,095 Added 2.53%
206,682 $3.47 Million
Q4 2021

Feb 11, 2022

BUY
$16.79 - $20.37 $23,321 - $28,293
1,389 Added 0.69%
201,587 $4.03 Million
Q3 2021

Nov 12, 2021

BUY
$18.14 - $27.03 $711,196 - $1.06 Million
39,206 Added 24.35%
200,198 $3.63 Million
Q2 2021

Aug 13, 2021

BUY
$25.24 - $30.86 $3,811 - $4,659
151 Added 0.09%
160,992 $4.35 Million
Q1 2021

May 14, 2021

SELL
$28.29 - $39.89 $223,604 - $315,290
-7,904 Reduced 4.68%
160,841 $4.82 Million
Q4 2020

Feb 05, 2021

BUY
$24.45 - $31.59 $20,293 - $26,219
830 Added 0.49%
168,745 $4.85 Million
Q3 2020

Nov 06, 2020

SELL
$17.22 - $24.59 $469,417 - $670,323
-27,260 Reduced 13.97%
167,915 $4.1 Million
Q2 2020

Aug 13, 2020

SELL
$6.46 - $19.27 $52,920 - $157,859
-8,192 Reduced 4.03%
195,175 $3.49 Million
Q1 2020

May 14, 2020

SELL
$5.64 - $15.23 $79,935 - $215,854
-14,173 Reduced 6.52%
203,367 $1.66 Million
Q4 2019

Feb 14, 2020

BUY
$8.8 - $14.93 $184,324 - $312,723
20,946 Added 10.65%
217,540 $2.87 Million
Q3 2019

Nov 01, 2019

SELL
$11.76 - $25.57 $112,978 - $245,650
-9,607 Reduced 4.66%
196,594 $2.34 Million
Q2 2019

Aug 02, 2019

BUY
$22.88 - $33.27 $576,621 - $838,470
25,202 Added 13.92%
206,201 $5.04 Million
Q1 2019

May 02, 2019

BUY
$31.52 - $46.19 $5.71 Million - $8.36 Million
180,999 New
180,999 $5.77 Million

Others Institutions Holding CVET

About COVETRUS, INC.


  • Ticker CVET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 140,123,008
  • Description
  • Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...
More about CVET
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.